File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Response to Letter to the Editor by Bihua Yao and Jianguo Wu

TitleResponse to Letter to the Editor by Bihua Yao and Jianguo Wu
Authors
Li, ChangCheung, Ka Shing
Keywordsempagliflozin
gut microbiota
MAFLD
NAFLD
SGLT2 inhibitors
treatment response
Issue Date8-May-2025
PublisherWiley
Citation
Liver International, 2025, v. 45, n. 6 How to Cite?
DOI: http://dx.doi.org/10.1111/liv.70134
Persistent Identifierhttp://hdl.handle.net/10722/359094
ISSN
1478-3223
2023 Impact Factor: 6.0
2023 SCImago Journal Rankings: 2.087

 

DC FieldValueLanguage
dc.contributor.authorLi, Chang-
dc.contributor.authorCheung, Ka Shing-
dc.date.accessioned2025-08-21T00:35:15Z-
dc.date.available2025-08-21T00:35:15Z-
dc.date.issued2025-05-08-
dc.identifier.citationLiver International, 2025, v. 45, n. 6-
dc.identifier.issn1478-3223-
dc.identifier.urihttp://hdl.handle.net/10722/359094-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofLiver International-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectempagliflozin-
dc.subjectgut microbiota-
dc.subjectMAFLD-
dc.subjectNAFLD-
dc.subjectSGLT2 inhibitors-
dc.subjecttreatment response-
dc.titleResponse to Letter to the Editor by Bihua Yao and Jianguo Wu-
dc.typeArticle-
dc.identifier.doi10.1111/liv.70134-
dc.identifier.scopuseid_2-s2.0-105004702768-
dc.identifier.volume45-
dc.identifier.issue6-
dc.identifier.eissn1478-3231-
dc.identifier.issnl1478-3223-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats